For: | Li F, Li H, Luo R, Pei JB, Yu XY. Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation. World J Clin Cases 2023; 11(26): 6066-6072 [PMID: 37731575 DOI: 10.12998/wjcc.v11.i26.6066] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i26/6066.htm |
Number | Citing Articles |
1 |
Christos Kourek, Alexandros Briasoulis, Grigorios Giamouzis, John Skoularigis, Andrew Xanthopoulos. Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure. World Journal of Clinical Cases 2023; 11(36): 8603-8605 doi: 10.12998/wjcc.v11.i36.8603
Abstract(340) |
Core Tip(293) |
Full Article(HTML)(1202)
|
Full Article with Cover (PDF)-878K(37)
|
Full Article (Word)-231K(18)
|
Audio-1095K(6)
|
Peer-Review Report-212K(27)
|
Answering Reviewers-119K(27)
|
Full Article (PDF)-514K(86)
|
Full Article (XML)-21K(34)
|
Times Cited (1)
|
Total Visits (2882)
|
Open
|
2 |
启俊 刘. Application Progress of Recombinant Human Brain Natriuretic Peptide in Clinical Practice. Advances in Clinical Medicine 2024; 14(04): 2573 doi: 10.12677/acm.2024.1441330
|
3 |
Dahuan Shi, Xin Li, Lantao Yang, Chunmei Luo, Jing Ma. Benefits of recombinant human brain natriuretic peptide to improve ventricular function and hemodynamics in patients with ST-elevation myocardial infarction.. Investigación Clínica 2024; 65(3): 335 doi: 10.54817/IC.v65n3a06
|